The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response
Open accessAbstract
The Keap1-Nrf2 system plays a central role in cytoprotection against electrophilic/oxidative stresses. Although Cys151, Cys273, and Cys288 of Keap1 are major sensor cysteine residues for detecting these stresses, it has not been technically feasible to evaluate the functionality of Cys273 or Cys288, since Keap1 mutants that harbor substitutions in these residues and maintain the ability to repress Nrf2 accumulation do not exist. To overcome this problem, we systematically introduced amino acid substitutions into Cys273/Cys288 and finally identified Cys273Trp and Cys288Glu mutations that do not affect Keap1's ability to repress Nrf2 accumulation. Utilizing these Keap1 mutants, we generated stable murine embryonic fibroblast (MEF) cell lines and knock-in mouse lines. Our analyses with the MEFs and peritoneal macrophages from the knock-in mice revealed that three major cysteine residues, Cys151, Cys273, and Cys288, individually and/or redundantly act as sensors. Based on the functional necessity of these three cysteine residues, we categorized chemical inducers of Nrf2 into four classes. Class I and II utilizes Cys151 and Cys288, respectively, while class III requires all three residues (Cys151/Cys273/Cys288), while class IV inducers function independently of all three of these cysteine residues. This study thus demonstrates that Keap1 utilizes multiple cysteine residues specifically and/or collaboratively as sensors for the detection of a wide range of environmental stresses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, an intriguing study in peritoneal tumours (B16 melanoma and ID8 ovarian carcinoma) has demonstrated that tumour-infiltrating macrophages release itaconate which potentiates tumour growth74.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [74]
In the citing paper
“Itaconate was shown to boost OXPHOS and mtROS generation and subsequent MAPK activation in tumour-infiltrating macrophages (Figure 3).”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Self-citationZhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,284
Molecular basis of the Keap1–Nrf2 system
Suzuki, T., & Yamamoto, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.006 · Cited by 995
Self-citationWakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986
Self-citationKeap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., KOTSUJI, T., Otsuka, F., Roop, D. R., et al. (2003) · Nature Genetics · doi:10.1038/ng1248 · Cited by 881
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Dinkova-Kostova AT, 2008, Mol Nutr Food Res, 52, S128
Cited by
Sorted by citations
Items 101–200 of 296
Bender, D., & Hildt, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184659 · Cited by 56
Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism
Horn, C. M., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621750 · Cited by 53
Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1
Deng, P.-X., Silva, M., Yang, N., Wang, Q., Meng, X., Ye, K., Gao, H., & Zheng, W. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01378-6 · Cited by 53
Pathophysiology of reactive oxygen species (ROS)
de la Lastra, J. M. P., Andrés, C. M. C., Munguira, E. B., Juan, C. A., & Pérez‐Lebeña, E. (2026) · Archives of Toxicology · doi:10.1007/s00204-025-04276-w · Cited by 61
CDDO-imidazolide Targets Multiple Amino Acid Residues on the Nrf2 Adaptor, Keap1
Meng, X., Waddington, J. C., Tailor, A., Lister, A., Hamlett, J., Berry, N. G., Park, B. K., & Sporn, M. B. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01088 · Cited by 50
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
Ko, Y., Hong, M., Lee, S., Kumar, M., Ibrahim, L. H., Nutsch, K., Stanton, C. R., Sondermann, P., Sandoval, B. A., Bulos, M. L., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300763120 · Cited by 49
The KEAP1-NRF2 System and Esophageal Cancer
Hirose, W., Oshikiri, H., Taguchi, K., & Yamamoto, M. P. (2022) · Cancers · doi:10.3390/cancers14194702 · Cited by 48
Self-citationMcMahon, M. J., Swift, S., & Hayes, J. D. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.033 · Cited by 46
Significance of NRF2 in physiological and pathological conditions an comprehensive review
Kryszczuk, M., & Kowalczuk, O. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109417 · Cited by 44
Baird, L., & Yamamoto, M. P. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-20 · Cited by 44
Self-citationMultifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Panda, H., Wen, H., Suzuki, M., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11030538 · Cited by 46
Self-citationUnoki, T., Akiyama, M., & Kumagai, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020545 · Cited by 43
mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance
Woo, Y., Lee, H.-J., Jung, Y. M., & Jung, Y. (2019) · Journal of Oncology · doi:10.1155/2019/5956867 · Cited by 42
Goel, F., Singh, P., Nand, S., & Yadav, D. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05517-w · Cited by 41
The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice
Higashi, C., Kawaji, A., Tsuda, N., Hayashi, M., Saito, R., Yagishita, Y., Suzuki, T., Uruno, A., Nakamura, M., Nakao, K., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.02.044 · Cited by 44
Self-citationRegulation of stress signaling pathways by protein lipoxidation
Patinen, T., Adinolfi, S., Cortés, C., Härkönen, J., Deen, A. J., & Levonen, A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101114 · Cited by 39
Long, T., Yang, Y., Peng, L., & Li, Z. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-1022-x · Cited by 40
Wdr1 and cofilin are necessary mediators of immune-cell-specific apoptosis triggered by Tecfidera
Poganik, J. R., Huang, K., Parvez, S., Zhao, Y., Raja, S., Long, M. J. C., & Aye, Y. (2021) · Nature Communications · doi:10.1038/s41467-021-25466-x · Cited by 35
More than Just Antioxidants: Redox-Active Components and Mechanisms Shaping Redox Signalling Network
Kuczyńska, M., Jakubek, P., & Bartoszek, A. (2022) · Antioxidants · doi:10.3390/antiox11122403 · Cited by 38
Sun, X., Guo, C., Huang, C., Lv, N., Chen, H., Huang, H., Zhao, Y., Sun, S., Zhao, D., Tian, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103116 · Cited by 36
Development of an oxidative stress in vitro assay in zebrafish (Danio rerio) cell lines
Lungu-Mitea, S., Oskarsson, A., & Lundqvist, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30880-1 · Cited by 36
Electrophilic metabolites targeting the KEAP1/NRF2 partnership
Dinkova‐Kostova, A. T., Hakomäki, H., & Levonen, A. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102425 · Cited by 34
Zhang, Y., Qin, S., Song, Y., Yuan, J., Hu, S., Chen, M., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857242 · Cited by 35
Wakamori, S., Taguchi, K., Nakayama, Y., Ohkoshi, A., Sporn, M. B., Ogawa, T., Katori, Y., & Yamamoto, M. P. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.06.239 · Cited by 34
Self-citationGatbonton-Schwager, T. N., Yagishita, Y., Joshi, T. V., Wakabayashi, N., Srinivasan, H., Suzuki, T., Yamamoto, M. P., & Kensler, T. W. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000671 · Cited by 34
Self-citationThe role of NRF2 transcription factor in inflammatory skin diseases
Salman, S., Paulet, V., Hardonnière, K., & Kerdine‐Römer, S. (2025) · BioFactors · doi:10.1002/biof.70013 · Cited by 43
Shrishrimal, S., Chatterjee, A., Kosmacek, E. A., Davis, P. J., McDonald, J. T., & Oberley‐Deegan, R. E. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.014 · Cited by 35
The β -TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo
Kuga, A., Tsuchida, K., Panda, H., Horiuchi, M., Otsuki, A., Taguchi, K., Katsuoka, F., Suzuki, M., & Yamamoto, M. P. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00563-21 · Cited by 34
Self-citationJain, R., Vora, L. K., Nathiya, D., & Khatri, D. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05389-0 · Cited by 36
Paunkov, A., Chartoumpekis, D., Ziros, P. G., Chondrogianni, N., Kensler, T., & Sykiotis, G. (2019) · Current pharmaceutical design · doi:10.2174/1381612825666190701165821 · Cited by 33
Distinct Regulations of HO-1 Gene Expression for Stress Response and Substrate Induction
Zhang, A., Suzuki, T., Adachi, S., Naganuma, E., Suzuki, N., Hosoya, T., Itoh, K., Sporn, M. B., & Yamamoto, M. P. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00236-21 · Cited by 31
Self-citationNaidu, S. D., Suzuki, T., Dikovskaya, D., Knatko, E. V., Higgins, M., Sato, M., Novak, M. J., Villegas, J. A., Moore, T. W., Yamamoto, M. P., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103703 · Cited by 33
Self-citationWible, R. S., & Sutter, T. R. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00428 · Cited by 33
Li, G., Li, D., Wu, C., Li, S., Chen, F., Li, P., Ko, C.-N., Wang, W., Lee, S. M., Lin, L., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00804-1 · Cited by 32
NRF2 is a critical regulator and therapeutic target of metal implant particle-incurred bone damage
Dong, J. P., Zhang, L., Ruan, B., Lv, Z., Wang, H., Wang, Y., Jiang, Q. Y., & Cao, W. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121742 · Cited by 31
Liu, M., Liu, S., Lin, Z.-H., Chen, X., Jiao, Q., Du, X., & Jiang, H. F. (2025) · Biomolecules · doi:10.3390/biom15010149 · Cited by 32
Small Molecular Nrf2 Inhibitors as Chemosensitizers for Cancer Therapy
Lin, H., Qiao, Y., Yang, H., Nan, Q., Qu, W., Feng, F., Liu, W., Chen, Y., & Sun, H. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0285 · Cited by 30
Nrf2 activation improves experimental rheumatoid arthritis
Zhang, A., Suzuki, T., Adachi, S., Yoshida, E., Sakaguchi, S., & Yamamoto, M. P. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.016 · Cited by 30
Self-citationReactive Chemicals and Electrophilic Stress in Cancer: A Minireview
Sakanyan, V. A. (2018) · Microarrays · doi:10.3390/ht7020012 · Cited by 30
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 29
Nrf2-Keap1 in Cardiovascular Disease: Which Is the Cart and Which the Horse?
Dhyani, N., Tian, C., Gao, L., Rudebush, T., & Zucker, I. H. (2024) · Physiology · doi:10.1152/physiol.00015.2024 · Cited by 30
Thiosulphate sulfurtransferase: Biological roles and therapeutic potential
Luo, Y., Melhem, S., Feelisch, M., Châtre, L., Morton, N. M., Dolga, A. M., & van Goor, H. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103595 · Cited by 30
Perspectives on the Clinical Development of NRF2-Targeting Drugs
Lastra, D., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_381 · Cited by 29
Zhao, Z., Dong, R., You, Q., & Jiang, Z. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00712 · Cited by 28
Regulation of stress signaling pathways by nitro-fatty acids
Deen, A. J., Sihvola, V., Härkönen, J., Patinen, T., Adinolfi, S., & Levonen, A. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.012 · Cited by 27
Shilovsky, G. A., & Dibrova, D. V. (2023) · Life · doi:10.3390/life13041045 · Cited by 27
Ma, Y., Li, C., Su, W.-P., Sun, Z., Gao, S., Xie, W. D., Zhang, B., & Sui, L. (2025) · Antioxidants · doi:10.3390/antiox14050577 · Cited by 32
Bailly, C. (2021) · Biomedicines · doi:10.3390/biomedicines9101325 · Cited by 27
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
Arslanbaeva, L. R., & Bisaglia, M. (2022) · Molecules · doi:10.3390/molecules27051471 · Cited by 27
Novel NRF2 ‐activated cancer treatments utilizing synthetic lethality
Baird, L., Kensler, T. W., & Yamamoto, M. P. (2022) · IUBMB Life · doi:10.1002/iub.2680 · Cited by 26
Self-citationAndrés, C. M. C., Lobo, F., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Lebeña, E. P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090765 · Cited by 28
Sun, D., Cui, S., Ma, H., Zhu, P., Li, N., Zhang, X., Zhang, L., Xuan, L., & Li, J. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115331 · Cited by 25
Zhang, Y., Li, L., Qin, S., Yuan, J., Xie, X., Wang, F., Hu, S., Yi, Y., & Chen, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.996614 · Cited by 27
Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
Chauhan, W., & Zennadi, R. (2023) · Antioxidants · doi:10.3390/antiox12030740 · Cited by 27
Sensor systems of KEAP1 uniquely detecting oxidative and electrophilic stresses separately In vivo
Sato, M., Yaguchi, N., Iijima, T., Muramatsu, A., Baird, L., Suzuki, T., & Yamamoto, M. P. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103355 · Cited by 24
Self-citationNrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management
Dewanjee, S., Bhattacharya, H., Bhattacharyya, C., Chakraborty, P., Fleishman, J. S., Alexiou, A. T., Papadakis, M., & Jha, S. K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01878-2 · Cited by 29
Wible, R. S., Tran, Q. T., Fathima, S., Sutter, T. R., Kensler, T. W., & Sutter, T. R. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.110262 · Cited by 24
Funakoshi‐Tago, M., Matsutaka, M., Hokimoto, S., Kobata, K., Tago, K., & Tamura, H. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104980 · Cited by 24
NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression
Buttari, B., Arese, M., Oberley‐Deegan, R. E., Saso, L., & Chatterjee, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.989793 · Cited by 24
Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate
Gille, A., Turkistani, A., Tsitsipatis, D., Hou, X., Tauber, S., Hamann, I., Urban, N., Erler, K., Steinbrenner, H., & Klotz, L. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.010 · Cited by 23
Ohnishi, M., Ohshita, M., Tamaki, H., Marutani, Y., Nakayama, Y., Akagi, M., Miyata, M., Maehara, S., Hata, T., & Inoue, A. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.029 · Cited by 23
Snijders, K. E., Fehér, A., Táncos, Z., Bock, I., Téglási, A., van den Berk, L., Niemeijer, M., Bouwman, P., Dévédec, S. E. L., Moné, M. J., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03127-8 · Cited by 23
Muchtaridi, M., Amirah, S. R., Harmonis, J. A., & Ikram, E. H. K. (2022) · Antioxidants · doi:10.3390/antiox11081551 · Cited by 26
Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer
Zeng, Z., Wang, Z., Li, Y., Ye, D., Zeng, J., Hu, J., Chen, P.-F., Xiao, J., Zou, J., & Li, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117325 · Cited by 22
Elhassanny, A. E. M., Ladin, D. A., Soliman, E., Albassam, H., Morris, A. J., Kobet, R. A., Thayne, K. A., Burns, C., Danell, A. S., & Dross, R. V. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.03.001 · Cited by 20
The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus
Barati, M. T., & Caster, D. J. (2022) · Metabolites · doi:10.3390/metabo12020151 · Cited by 23
NRF2 signaling in cytoprotection and metabolismPreprint
Murakami, S., Kusano, Y., Okazaki, K., Akaike, T., & Motohashi, H. (2023) · doi:10.22541/au.168872044.49044735/v1 · Cited by 20
NRF2 Is an Upstream Regulator of MYC-Mediated Osteoclastogenesis and Pathological Bone Erosion
Park, P. S. U., Mun, S. H., Zeng, S. L., Kim, H., Bae, S., & Park‐Min, K. (2020) · Cells · doi:10.3390/cells9092133 · Cited by 19
Transcription Factor NRF2 in Shaping Myeloid Cell Differentiation and Function
Pfefferlé, M., & Vallelian, F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-62731-6_8 · Cited by 18
Regulation of the CNC-bZIP transcription factor Nrf2 by Keap1 and the axis between GSK-3 and β-TrCP
Hayes, J. D., Ebisine, K., Sharma, R. S., Chowdhry, S., Dinkova‐Kostova, A. T., & Sutherland, C. D. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.003 · Cited by 19
Free Radical Research in Cancer
Gašparović, A. Č. (2020) · Antioxidants · doi:10.3390/antiox9020157 · Cited by 21
Luo, Y., Châtre, L., Melhem, S., Al-Dahmani, Z. M., Homer, N. Z. M., Miedema, A., Deelman, L. E., Groves, M. R., Feelisch, M., Morton, N. M., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102965 · Cited by 18
Lu, M., Zhou, H.-S., You, Q., & Jiang, Z. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00775 · Cited by 18
Zhang, B., Ma, Z., Tan, B., & Lin, N. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1559824 · Cited by 18
Biagiotti, S., Bianchi, M., Rossi, L., Chessa, L., & Magnani, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216668 · Cited by 17
Poh, J., Ponsford, A. H., Boyd, J., Woodsmith, J., Stelzl, U., Wanker, E. E., Harper, N., MacEwan, D. J., & Sanderson, C. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101686 · Cited by 17
Bidirectional regulation of KEAP1 BTB domain-based sensor activity
Suzuki, T., Takagi, K., Iso, T., Wen, H., Zhang, A., Hatakeyama, T., Oshima, H., Mizushima, T., & Yamamoto, M. P. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103885 · Cited by 16
Self-citationThe Keap1-Nrf2 pathway: From mechanism to medical applications
Baird, L., & Yamamoto, M. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00009-2 · Cited by 16
Self-citationPensabene, K. M., LaMorte, J. P., Allender, A., Wehr, J., Kaur, P., Savage, M., & Eggler, A. L. (2023) · Antioxidants · doi:10.3390/antiox12091735 · Cited by 16
The Complex Roles of Redox and Antioxidant Biology in CancerPreprint
Hayashi, M., Okazaki, K., Papgiannakopoulos, T., & Motohashi, H. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041546 · Cited by 16
Schnell, M. R., Zhai, T., Ragwan, E., Jung, H.-C., Zhang, J., Lagalante, A. F., Kung, Y., Kraut, D. A., Huang, Z. J., & Eggler, A. L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103906 · Cited by 15
Repash, E. M., Pensabene, K. M., Palenchar, P. M., & Eggler, A. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.686201 · Cited by 15
Dikovskaya, D., Appleton, P. L., Bento‐Pereira, C., & Dinkova‐Kostova, A. T. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00354 · Cited by 15
Z-REX uncovers a bifurcation in function of Keap1 paralogs
Hall‐Beauvais, A. V., Poganik, J. R., Huang, K., Parvez, S., Zhao, Y., Lin, H., Liu, X., Long, M. J. C., & Aye, Y. (2022) · eLife · doi:10.7554/elife.83373 · Cited by 14
Xu, Z., Bai, J., Min, M., Cao, J., Zhang, Y., Li, L., Cao, J., Ma, X., Xu, Y., & Ma, L. (2024) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2023.105765 · Cited by 14
Fuse, Y., Endo, Y., Araoi, S., Daitoku, H., Suzuki, H., Kato, M., & Kobayashi, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.022 · Cited by 14
Takeda, H., Nakajima, Y., Yamaguchi, T., Watanabe, I., Miyoshi, S., Nagashio, K., Sekine, H., Motohashi, H., Yano, H., & Tanaka, J. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad030 · Cited by 12
Kim, H. K., Jeong, H., Jeong, M. G., Won, H. Y., Lee, G., Bae, S. H., Nam, M., Lee, S. H., Hwang, G., & Hwang, E. S. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.88897 · Cited by 12
Stress-Free Evolution: The Nrf-Coordinated Oxidative Stress Response in Early Diverging Metazoans
Doonan, L. B., Hartigan, A., Okamura, B., & Long, P. F. (2019) · Integrative and Comparative Biology · doi:10.1093/icb/icz055 · Cited by 12
Zhou, J., Zhang, X., Tang, H., Yu, J., Zu, X., Xie, Z., Yang, X., Hu, J., Tan, F., Li, Q., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.02.028 · Cited by 12
Lee, J. A., Kim, H. R., Son, H. J., Shin, N., Han, S. H., Cheong, C. S., Kim, D. J., & Hwang, O. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113387 · Cited by 12
Niino, T., Tago, K., Yasuda, D., Takahashi, K., Mashino, T., Tamura, H., & Funakoshi‐Tago, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.021 · Cited by 12
Panda, H., Keleku-Lukwete, N., Kuga, A., Fuke, N., Suganuma, H., Suzuki, M., & Yamamoto, M. P. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.08.001 · Cited by 11
Self-citationThe Keap1 signaling in the regulation of HSP90 pathway
Bonura, A., Giacomarra, M., & Montana, G. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01253-5 · Cited by 13
Vargas-Mendoza, N., Morales‐González, Á., Madrigal‐Santillán, E., Ángeles-Valencia, M., Anguiano‐Robledo, L., González-López, L. L., Sosa-Gómez, A., Fregoso-Aguilar, T. A., Esquivel-Chirino, C., Ruiz-Velazco-Benítez, Y. A., et al. (2022) · PubMed Central · Cited by 12
Bauman, B. M., Jeong, C., Savage, M., Briker, A., Janigian, N. G., Nguyen, L. L., Kemmerer, Z. A., & Eggler, A. L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.039 · Cited by 11
Reappraisal of Oxidized HMGB1 As a Mediator and Biomarker
Pirnie, R., Gillespie, K. P., Mesaros, C., & Blair, I. A. (2022) · Future Science OA · doi:10.2144/fsoa-2022-0052 · Cited by 10
Huang, K., Poganik, J. R., Parvez, S., Raja, S., Miller, B., Long, M. J. C., Fetcho, J. R., & Aye, Y. (2023) · Nature Protocols · doi:10.1038/s41596-023-00809-8 · Cited by 8
Zatloukalová, M., Jedinák, L., Riman, D., Franková, J., Novák, D., Cytryniak, A., Nazaruk, E., Bilewicz, R., Vrba, J., Papoušková, B., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102097 · Cited by 11
Yamauchi, T., Okano, Y., Terada, D., Yasukochi, S., Tsuruta, A., Tsurudome, Y., Ushijima, K., Matsunaga, N., Koyanagi, S., & Ohdo, S. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00352-4 · Cited by 9
Metadata
- Authors
- Saito, R., Suzuki, T., Hiramoto, K., Asami, S., Naganuma, E., Suda, H., Iso, T., Yamamoto, H., Morita, M., Baird, L., Furusawa, Y., Negishi, T., Ichinose, M., & Yamamoto, M.
- Affiliations
- Tohoku University (JP)
- Mochida Pharmaceutical (Japan) (JP)
- Corresponding author
- Suzuki, Takafumi
- Yamamoto, Masayuki
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2016-01-01
- Volume
- 36
- Issue
- 2
- Pages
- 271-284
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC4719294
- OpenAlex
- W2202703189
- Cited by
- 294
- References
- 47
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 23 · 2023: 26 · 2022: 36 · 2021: 21 · 2020: 48 · 2019: 24 · 2018: 28 · 2017: 14 · 2016: 14
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- P-DIRECT
- Ministry of Education, Culture, Sports, Science, and Technology (24249015, 26111002, 26460354, 25112502, 2611010)
- Takeda Science Foundation
- AMED-CREST, Japan Agency for Medical Research and Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- Keap1, Nrf2, oxidative stress, electrophilic stress, Nrf2 inducers, peritoneal macrophages, murine embryonic fibroblasts, cytoprotection
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Amino Acid Sequence, Animals, Cell Line, Cysteine, Cytoskeletal Proteins, Humans, Mice, Transgenic, Molecular Sequence Data, Mutation, Transfection, Sequence Alignment, Oxidative Stress, Amino Acid Substitution, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, NF-E2-Related Factor 2, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
